RxDoctor Payments Data

Mehrdad Farahmand, MD

Surgery · Colville, WANPI 1629066733

Payments from drug & device makers

$538in general payments, 2019–2025

Across 26 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$262
  • Novo Nordisk$94
  • Boehringer Ingelheim$83
  • Tandem Diabetes Care, Inc.$59
  • Sanofi-aventis U.S. LLC$16
  • AstraZeneca$13
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$538100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$538 in reported general payments places this provider in the 35th percentile of 549 surgery providers in Washington.

See all surgery providers in Washington

Medicare billing

Part B allowed, 2024
$25,702
Medicare patients
72
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl14$49

Paid to pharmacies, not to this prescriber.

Other surgery in Colville

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →